Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Oct 30, 2019 2:28pm

144 Views

Post# 30287887

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesions

Good input Claridge thanks .... it just wouldn't make sense not to publish that would mean too much uncertainty among existing and future shareholders, the 3 month, 6 month and 1 year targets are very important to both the company and shareholders. I guess that expression "" thank God it's friday"" will be met with cheers for the IND approval.

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments